Suven Pharmaceuticals Limited
NSE:SUVENPHAR.NS
1239.8 (INR) • At close October 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||||||
| Net Income
| 607.7 | 533.73 | 467.535 | 795.641 | 1,205.899 | 1,239.71 | 1,077.206 | 720.563 | 1,075.421 | 916.68 | 1,600.69 | 969.848 | 1,050.831 | 831.159 | 1,136.253 | 740.79 | 915.216 | 741.823 | 579.104 | 930.048 | 919.042 | 748.23 | 394.668 |
| Depreciation & Amortization
| 0 | 0 | 127.518 | 118.919 | 125.412 | 119.583 | 122.39 | 120.305 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 59.207 | 59.207 | 59.207 | 59.207 | 0 | 28.742 | 28.742 | 28.742 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 19.945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 113.07 | 113.07 | 113.07 | 113.07 | 0 | -220.817 | -220.817 | -220.817 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -44.435 | -44.435 | -44.435 | -44.435 | 0 | -42.723 | -42.723 | -42.723 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 157.504 | 157.504 | 157.504 | 157.504 | 0 | -178.094 | -178.094 | -178.094 |
| Other Non Cash Items
| -607.7 | -553.675 | -467.535 | -795.641 | -1,205.899 | -1,239.71 | -1,077.206 | -720.563 | -1,075.421 | -916.68 | -1,600.69 | -969.848 | -1,050.831 | -831.159 | -1,136.253 | -740.79 | -915.216 | -741.823 | -579.104 | -930.048 | -919.042 | -748.23 | -76.582 |
| Operating Cash Flow
| 0 | 0 | 255.036 | 237.838 | 250.824 | 239.166 | 244.78 | 240.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,039.875 | 1,039.875 | 1,039.875 | 1,039.875 | 0 | 126.012 | 126.012 | 126.012 |
| Investing Activities: | |||||||||||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -248.537 | -248.537 | -248.537 | -248.537 | 0 | -141.965 | -141.965 | -141.965 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 248.537 | 248.537 | 248.537 | 248.537 | 0 | 141.965 | 141.965 | 141.965 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -211.973 | -211.973 | -211.973 | -211.973 | 0 | -146.949 | -146.949 | -146.949 |
| Financing Activities: | |||||||||||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -191.807 | -191.807 | -191.807 | -191.807 | 0 | -57.542 | -57.542 | -57.542 |
| Other Financing Activities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 191.807 | 191.807 | 191.807 | 191.807 | 0 | 57.542 | 57.542 | 57.542 |
| Financing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -191.807 | -191.807 | -191.807 | -191.807 | 0 | -57.542 | -57.542 | -57.542 |
| Other Information: | |||||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -634.114 | -634.114 | -634.114 | -634.114 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0 | 0 | 255.036 | 237.838 | 250.824 | 239.166 | 244.78 | 240.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.981 | 1.981 | 1.981 | 1.981 | 0 | -78.479 | -78.479 | -78.479 |
| Cash At End Of Period
| 0 | 0 | 863.095 | 608.059 | 909.424 | 658.6 | 1,094.767 | 849.987 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.238 | 29.238 | 29.238 | 29.238 | 0 | 27.257 | 27.257 | 27.257 |